Are Medical Stocks Lagging Boston Scientific (BSX) This Year?

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Boston Scientific (BSX) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.Boston Scientific is a member of the Medical sector. This group includes 973 individual stocks and currently holds a Zacks Sector Rank of #8. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Boston Scientific is currently sporting a Zacks Rank of #2 (Buy).Over the past three months, the Zacks Consensus Estimate for BSX's full-year earnings has moved 2.1% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.Our latest available data shows that BSX has returned about 18.4% since the start of the calendar year. Meanwhile, stocks in the Medical group have lost about 2.8% on average. This means that Boston Scientific is performing better than its sector in terms of year-to-date returns.Another stock in the Medical sector, Allarity Therapeutics, Inc. (ALLR), has outperformed the sector so far this year. The stock's year-to-date return is 28.2%.Over the past three months, Allarity Therapeutics, Inc.'s consensus EPS estimate for the current year has increased 97.4%. The stock currently has a Zacks Rank #2 (Buy).Looking more specifically, Boston Scientific belongs to the Medical - Products industry, a group that includes 84 individual stocks and currently sits at #96 in the Zacks Industry Rank. Stocks in this group have gained about 7.1% so far this year, so BSX is performing better this group in terms of year-to-date returns. On the other hand, Allarity Therapeutics, Inc. belongs to the Medical - Biomedical and Genetics industry. This 486-stock industry is currently ranked #99. The industry has moved +2.7% year to date.Investors interested in the Medical sector may want to keep a close eye on Boston Scientific and Allarity Therapeutics, Inc. as they attempt to continue their solid performance.Zacks Names #1 Semiconductor StockThis under-the-radar company specializes in semiconductor products that titans like NVIDIA don't build. It's uniquely positioned to take advantage of the next growth stage of this market. And it's just beginning to enter the spotlight, which is exactly where you want to be.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $971 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Boston Scientific Corporation (BSX): Free Stock Analysis Report Allarity Therapeutics, Inc. (ALLR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks